RU95114740A - Peptides - Google Patents
PeptidesInfo
- Publication number
- RU95114740A RU95114740A RU95114740/04A RU95114740A RU95114740A RU 95114740 A RU95114740 A RU 95114740A RU 95114740/04 A RU95114740/04 A RU 95114740/04A RU 95114740 A RU95114740 A RU 95114740A RU 95114740 A RU95114740 A RU 95114740A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- complex
- radionuclide
- pharmaceutically acceptable
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 12
- 150000003839 salts Chemical group 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000003381 stabilizer Substances 0.000 claims 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N Gentisic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000012217 radiopharmaceutical Substances 0.000 claims 2
- 102100001249 ALB Human genes 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 206010027476 Metastasis Diseases 0.000 claims 1
- 108010071390 Serum Albumin Proteins 0.000 claims 1
- 102000011096 Somatostatin receptor family Human genes 0.000 claims 1
- 108050001286 Somatostatin receptor family Proteins 0.000 claims 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229960005070 ascorbic acid Drugs 0.000 claims 1
- 235000010323 ascorbic acid Nutrition 0.000 claims 1
- 239000011668 ascorbic acid Substances 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 239000000824 cytostatic agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960005219 gentisic acid Drugs 0.000 claims 1
- 230000002799 radiopharmaceutical Effects 0.000 claims 1
- 229960003471 retinol Drugs 0.000 claims 1
- 235000020944 retinol Nutrition 0.000 claims 1
- 239000011607 retinol Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
Claims (13)
где М является катионом;
А является Рhе или Туr,
в свободной форме, в форме соли или комплекса с радионуклидом.1. The compound of formula I
where M is a cation;
A is Phe or Tur,
in free form, in salt form or complex with a radionuclide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417873A GB9417873D0 (en) | 1994-09-06 | 1994-09-06 | Organic compounds |
GB9417873.8 | 1994-09-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95114740A true RU95114740A (en) | 1997-08-27 |
RU2156774C2 RU2156774C2 (en) | 2000-09-27 |
Family
ID=10760870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95114740/04A RU2156774C2 (en) | 1994-09-06 | 1995-09-04 | Somastatinic peptides, radiopharmaceutical agent, method of treating tumors, and pharmaceutical composition |
Country Status (31)
Country | Link |
---|---|
US (2) | US6183721B1 (en) |
EP (1) | EP0714911B1 (en) |
JP (1) | JP3054346B2 (en) |
KR (1) | KR100364111B1 (en) |
CN (1) | CN1185252C (en) |
AT (1) | ATE199561T1 (en) |
AU (1) | AU703057B2 (en) |
BR (1) | BR9503936A (en) |
CA (1) | CA2157530C (en) |
CO (1) | CO4410344A1 (en) |
CZ (1) | CZ287012B6 (en) |
DE (1) | DE69520256T2 (en) |
DK (1) | DK0714911T3 (en) |
ES (1) | ES2157309T3 (en) |
FI (1) | FI117424B (en) |
GB (1) | GB9417873D0 (en) |
GR (1) | GR3035997T3 (en) |
HU (1) | HU218284B (en) |
IL (1) | IL115154A (en) |
NO (1) | NO316569B1 (en) |
NZ (1) | NZ272919A (en) |
PE (1) | PE41496A1 (en) |
PL (1) | PL182434B1 (en) |
PT (1) | PT714911E (en) |
RU (1) | RU2156774C2 (en) |
SG (1) | SG50356A1 (en) |
SI (1) | SI0714911T1 (en) |
SK (1) | SK283774B6 (en) |
TR (1) | TR199501094A2 (en) |
TW (1) | TW387898B (en) |
ZA (1) | ZA957475B (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9417873D0 (en) * | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
AT405906B (en) * | 1997-03-14 | 1999-12-27 | Irene Dr Virgolini | RADIO-MARKED SOMATOSTATIN RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY |
US6358491B1 (en) | 1999-08-27 | 2002-03-19 | Berlex Laboratories, Inc. | Somatostatin analogs |
PL414997A1 (en) | 2001-02-19 | 2016-02-29 | Novartis Ag | Application of 40-O-(2-hydroxyethyl)-rapamycin for treatment of solid kidney tumors |
JP2004529884A (en) | 2001-02-26 | 2004-09-30 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | Ascorbic acid analogs for metal radiopharmaceuticals |
ITMI20011708A1 (en) * | 2001-08-03 | 2003-02-03 | Bracco Imaging Spa | CONJUGATES OF PEPTIDES, THEIR DERIVATIVES WITH METALLIC COMPLEXES AND USE FOR DIAGNOSTIC INVESTIGATION THROUGH IMAGING FOR MAGNETIC RESONANCE (M |
NZ538284A (en) | 2002-07-18 | 2008-04-30 | Helix Biopharma Corp | Use of urease and targeting molecule for inhibiting cancer cell growth |
US20050118099A1 (en) * | 2003-03-10 | 2005-06-02 | Braslawsky Gary R. | Thiol-mediated drug attachment to targeting peptides |
WO2006009901A2 (en) | 2004-06-18 | 2006-01-26 | Ambrx, Inc. | Novel antigen-binding polypeptides and their uses |
US20100029911A1 (en) * | 2004-11-24 | 2010-02-04 | Aplagen Gmbh | Method For Solid-Phase Peptide Synthesis And Purification |
CA2699394C (en) | 2007-09-17 | 2020-03-24 | The Regents Of The University Of California | Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
EP2684048B1 (en) | 2011-03-11 | 2018-10-03 | Board of Regents of the University of Nebraska | Biomarker for coronary artery disease |
EP2922578B1 (en) | 2012-11-21 | 2018-12-12 | Serene, Llc | Tin-117m comprising somatostatin receptor binding compounds |
CN103275189B (en) * | 2013-06-06 | 2014-08-06 | 深圳翰宇药业股份有限公司 | Cracking liquid for peptide resin, and application thereof in synthesizing somatostatin by solid phase cracking |
US10946106B2 (en) | 2015-11-30 | 2021-03-16 | The Regents Of The University Of California | Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen |
US11235076B2 (en) | 2016-08-29 | 2022-02-01 | Fred Hutchinson Cancer Research Center | Chelating platform for delivery of radionuclides |
PT3568205T (en) | 2017-01-12 | 2023-10-26 | Radiomedix Inc | Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes |
TW202017600A (en) * | 2018-06-21 | 2020-05-16 | 法商艾普森藥品公司 | Composition containing a somatostatin analogue for radiopharmaceutical use |
TW202015744A (en) | 2018-06-21 | 2020-05-01 | 法商艾普森藥品公司 | Composition containing a somatostatin analogue for radiopharmaceutical use |
US10596276B2 (en) | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
US10596278B2 (en) | 2018-07-25 | 2020-03-24 | Advanced Accelerator Applications (Italy) S.R.L. | Stable, concentrated radionuclide complex solutions |
JP2023534765A (en) | 2020-08-07 | 2023-08-10 | フォーティス セラピューティクス,インク. | CD46 targeting immune complexes and methods of use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006643A (en) | 1987-06-24 | 1991-04-09 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
DE3728600A1 (en) | 1987-08-27 | 1989-03-09 | Hoechst Ag | METHOD FOR MARKING SUBSTANCES WITH TECHNETIUM OR RHENIUM |
AU630362B2 (en) * | 1988-05-25 | 1992-10-29 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Macrocyclic chelates & methods of use thereof |
GB9111199D0 (en) * | 1991-05-23 | 1991-07-17 | Sandoz Ltd | Improvements in or relating to organic compounds |
MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
WO1991004755A1 (en) | 1989-09-29 | 1991-04-18 | Neorx Corporation | Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
AU3967593A (en) * | 1992-03-25 | 1993-10-21 | Mallinckrodt Medical, Inc. | Method of intraoperatively detecting and locating tumoral tissues |
US5650134A (en) * | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
IL108308A0 (en) * | 1993-01-12 | 1994-04-12 | Sandoz Ag | Polypeptides, their production and pharmaceutical compositions containing them |
US5705143A (en) * | 1994-01-12 | 1998-01-06 | Amersham International Plc | Biological targeting agents |
GB9417873D0 (en) * | 1994-09-06 | 1994-10-26 | Sandoz Ltd | Organic compounds |
-
1994
- 1994-09-06 GB GB9417873A patent/GB9417873D0/en active Pending
-
1995
- 1995-09-04 CZ CZ19952263A patent/CZ287012B6/en not_active IP Right Cessation
- 1995-09-04 PE PE1995277844A patent/PE41496A1/en not_active IP Right Cessation
- 1995-09-04 EP EP95810545A patent/EP0714911B1/en not_active Expired - Lifetime
- 1995-09-04 AT AT95810545T patent/ATE199561T1/en active
- 1995-09-04 NZ NZ272919A patent/NZ272919A/en not_active IP Right Cessation
- 1995-09-04 DE DE69520256T patent/DE69520256T2/en not_active Expired - Lifetime
- 1995-09-04 PT PT95810545T patent/PT714911E/en unknown
- 1995-09-04 IL IL11515495A patent/IL115154A/en not_active IP Right Cessation
- 1995-09-04 DK DK95810545T patent/DK0714911T3/en active
- 1995-09-04 PL PL95310274A patent/PL182434B1/en unknown
- 1995-09-04 NO NO953457A patent/NO316569B1/en not_active IP Right Cessation
- 1995-09-04 ES ES95810545T patent/ES2157309T3/en not_active Expired - Lifetime
- 1995-09-04 AU AU30414/95A patent/AU703057B2/en not_active Expired
- 1995-09-04 HU HU9502577A patent/HU218284B/en unknown
- 1995-09-04 SI SI9530491T patent/SI0714911T1/en unknown
- 1995-09-04 SK SK1088-95A patent/SK283774B6/en not_active IP Right Cessation
- 1995-09-04 SG SG1995001282A patent/SG50356A1/en unknown
- 1995-09-04 RU RU95114740/04A patent/RU2156774C2/en active
- 1995-09-04 FI FI954147A patent/FI117424B/en not_active IP Right Cessation
- 1995-09-05 BR BR9503936-8A patent/BR9503936A/en not_active IP Right Cessation
- 1995-09-05 CO CO95040393A patent/CO4410344A1/en unknown
- 1995-09-05 JP JP7227906A patent/JP3054346B2/en not_active Expired - Lifetime
- 1995-09-05 CN CNB951156101A patent/CN1185252C/en not_active Expired - Lifetime
- 1995-09-05 KR KR1019950028905A patent/KR100364111B1/en not_active IP Right Cessation
- 1995-09-05 CA CA002157530A patent/CA2157530C/en not_active Expired - Lifetime
- 1995-09-06 TR TR95/01094A patent/TR199501094A2/en unknown
- 1995-09-06 ZA ZA957475A patent/ZA957475B/en unknown
- 1995-09-08 TW TW084109395A patent/TW387898B/en not_active IP Right Cessation
-
1997
- 1997-04-23 US US08/842,125 patent/US6183721B1/en not_active Expired - Lifetime
-
2000
- 2000-07-05 US US09/609,844 patent/US6277356B1/en not_active Expired - Lifetime
-
2001
- 2001-06-06 GR GR20010400850T patent/GR3035997T3/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95114740A (en) | Peptides | |
JP3036602B2 (en) | Technetium-99m labeled peptide for imaging | |
JP2954354B2 (en) | Technetium-99m labeled peptide for imaging | |
US5753205A (en) | Radiolabelled peptide compounds | |
JPH06503352A (en) | Technetium-99m labeled polypeptide for imaging | |
JPS59104377A (en) | Amino acid thiolactone | |
KR960010683A (en) | Somatostatin peptide, its preparation and pharmaceutical composition containing the same | |
KR920008065A (en) | Peptide Compounds, Methods For Making Them, And Pharmaceutical Compositions Containing Them | |
JPH07506111A (en) | Technetium-99m labeled peptide for contrast imaging | |
IE67637B1 (en) | Labeled Polypeptide Derivatives | |
RU93004764A (en) | AMIDA SULFAMIDO-AND SULFAMIDOKARBONYLPYRIDIN-2-CARBIC ACIDS, THEIR Pyridine-N-OXIDES, METHOD OF THEIR RECEIVING AND THEIR APPLICATION AS MEDICINE PREPARATIONS | |
JP2007523902A (en) | Technetium-bis (heteroaryl) and rhenium-bis (heteroaryl) complexes and methods of use thereof | |
JP2000515514A (en) | Analogous compounds of radiometal element binding peptides | |
HUP0003255A2 (en) | Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates | |
NO934837D0 (en) | Porphycene Compounds for Photodynamic Therapy | |
ES8506001A1 (en) | Fused imidazole compounds, processes for the preparation thereof and pharmaceutical compositions containing them. | |
ES2281927T3 (en) | TETRAAZA- OR N2S2- COMPLEXANTS, AND THEIR USE IN RADIODIAGNOSIS OR IN RADIOTHERAPY. | |
ES2892955T3 (en) | Bifunctional derivatives of do2pa, chelates with metal cations and their use | |
JP2954355B2 (en) | Radioisotope labeled compounds for thrombus imaging | |
EP0630264B1 (en) | Ligands for improving metal chelate formation kinetics | |
DK171487A (en) | Cationic complexes which contain technetium-99m, the complexes for use as heart-imaging agents, and ligands which can be used in such complexes | |
US5736120A (en) | Method for preparing radiolabeled peptides | |
ES376688A1 (en) | Benzdiazepine derivatives | |
CA2194294C (en) | Complexes for use in the diagnosis of vascular diseases | |
EP3849956A1 (en) | Fluorination method |